Drugs / Bone Marrow Concentrate (BMAC)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07434115 | Jan 2026 → Jan 2029 expected | musculoskeletal system disorder | PROREGEN | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bone Marrow Concentrate (BMAC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07434115 ↗ |